• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse.组织蛋白酶 S、L 和 B 在 NOD 小鼠胰岛炎和糖尿病中的作用。
J Autoimmun. 2010 Mar;34(2):96-104. doi: 10.1016/j.jaut.2009.07.003. Epub 2009 Aug 6.
2
Expression of human cathepsin L or human cathepsin V in mouse thymus mediates positive selection of T helper cells in cathepsin L knock-out mice.人组织蛋白酶 L 或人组织蛋白酶 V 在小鼠胸腺中的表达介导组织蛋白酶 L 敲除小鼠中辅助性 T 细胞的阳性选择。
Biochimie. 2010 Nov;92(11):1674-80. doi: 10.1016/j.biochi.2010.03.014. Epub 2010 Mar 25.
3
Cathepsin L is essential for onset of autoimmune diabetes in NOD mice.组织蛋白酶L对非肥胖糖尿病(NOD)小鼠自身免疫性糖尿病的发病至关重要。
J Clin Invest. 2005 Oct;115(10):2934-43. doi: 10.1172/JCI25485. Epub 2005 Sep 22.
4
Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis.组织蛋白酶表达的基因和药理学改变影响呼肠孤病毒的发病机制。
J Virol. 2009 Oct;83(19):9630-40. doi: 10.1128/JVI.01095-09. Epub 2009 Jul 29.
5
Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.保护性白细胞介素-2等位基因变体对NOD小鼠体内CD4+ Foxp3+调节性T细胞功能及自身免疫性糖尿病抗性的影响
J Immunol. 2008 Nov 1;181(9):6283-92. doi: 10.4049/jimmunol.181.9.6283.
6
Immunohistochemical Evaluation of Cathepsin B, L, and S Expression in Breast Cancer Patients.乳腺癌患者组织蛋白酶B、L和S表达的免疫组织化学评估
Mol Imaging Biol. 2024 Dec;26(6):1057-1067. doi: 10.1007/s11307-024-01955-5. Epub 2024 Sep 27.
7
Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.非肥胖糖尿病小鼠B细胞上B7-1和B7-2表达失调与T细胞共刺激增加及胰岛炎的发展有关。
J Immunol. 2005 Jan 15;174(2):680-7. doi: 10.4049/jimmunol.174.2.680.
8
Processing of human protryptase in mast cells involves cathepsins L, B, and C.人原胰蛋白酶在肥大细胞中的加工涉及组织蛋白酶 L、B 和 C。
J Immunol. 2011 Aug 15;187(4):1912-8. doi: 10.4049/jimmunol.1001806. Epub 2011 Jul 8.
9
Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis.组织蛋白酶 B 和 L 的双重缺失导致大量分泌组改变,并提示存在降解性组织蛋白酶-MMP 轴。
Cell Mol Life Sci. 2014 Mar;71(5):899-916. doi: 10.1007/s00018-013-1406-1. Epub 2013 Jun 29.
10
Cathepsin L inactivates human trypsinogen, whereas cathepsin L-deletion reduces the severity of pancreatitis in mice.组织蛋白酶 L 可使人类胰蛋白酶原失活,而组织蛋白酶 L 缺失可降低小鼠胰腺炎的严重程度。
Gastroenterology. 2010 Feb;138(2):726-37. doi: 10.1053/j.gastro.2009.10.048. Epub 2009 Nov 10.

引用本文的文献

1
CeO@CA-074Me Nanoparticles Alleviate Inflammation and Improve Osteogenic Microenvironment by Regulating the CTSB-NLRP3 Signaling Pathway.二氧化铈@CA-074Me纳米颗粒通过调节CTSB-NLRP3信号通路减轻炎症并改善成骨微环境。
Int J Nanomedicine. 2025 Jan 6;20:161-179. doi: 10.2147/IJN.S389156. eCollection 2025.
2
Identification of New Polyacetylenes from with PPAR-α Activity Study.从具有过氧化物酶体增殖物激活受体-α(PPAR-α)活性研究中鉴定新的聚乙炔类化合物。
Molecules. 2024 Dec 16;29(24):5942. doi: 10.3390/molecules29245942.
3
Uncovering the molecular networks of ferroptosis in the pathogenesis of type 2 diabetes and its complications: a multi-omics investigation.揭示铁死亡分子网络在2型糖尿病及其并发症发病机制中的作用:一项多组学研究
Mol Med. 2024 Dec 23;30(1):268. doi: 10.1186/s10020-024-01045-w.
4
Lysosomal physiology and pancreatic lysosomal stress in diabetes mellitus.糖尿病中的溶酶体生理学与胰腺溶酶体应激
eGastroenterology. 2024 Oct;2(3). doi: 10.1136/egastro-2024-100096. Epub 2024 Aug 29.
5
Is tear proteome profile a predictor of developing uveitis in ANA-positive patients with oligoarticular juvenile idiopathic arthritis?ANA 阳性寡关节型幼年特发性关节炎患者的眼内炎发生中,眼液蛋白质组谱是否可作为预测指标?
Graefes Arch Clin Exp Ophthalmol. 2024 Jan;262(1):211-221. doi: 10.1007/s00417-023-06251-6. Epub 2023 Sep 29.
6
Heterochronic Parabiosis Causes Dacryoadenitis in Young Lacrimal Glands.异时共生导致年轻泪腺发生泪腺炎。
Int J Mol Sci. 2023 Mar 3;24(5):4897. doi: 10.3390/ijms24054897.
7
The Key Role of Lysosomal Protease Cathepsins in Viral Infections.溶酶体蛋白酶组织蛋白酶在病毒感染中的关键作用。
Int J Mol Sci. 2022 Aug 13;23(16):9089. doi: 10.3390/ijms23169089.
8
Mucopolysaccharidosis Type IVA: Extracellular Matrix Biomarkers in Cardiovascular Disease.IVA型黏多糖贮积症:心血管疾病中的细胞外基质生物标志物
Front Cardiovasc Med. 2022 May 10;9:829111. doi: 10.3389/fcvm.2022.829111. eCollection 2022.
9
The Role of Proteases and Serpin Protease Inhibitors in β-Cell Biology and Diabetes.蛋白酶和丝氨酸蛋白酶抑制剂在β细胞生物学和糖尿病中的作用。
Biomolecules. 2022 Jan 2;12(1):67. doi: 10.3390/biom12010067.
10
Cathepsin S is a novel target for age-related dry eye.组织蛋白酶 S 是与年龄相关的干眼症的一个新靶点。
Exp Eye Res. 2022 Jan;214:108895. doi: 10.1016/j.exer.2021.108895. Epub 2021 Dec 12.

本文引用的文献

1
Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms.组织蛋白酶B、K和S在脑动脉瘤中表达,并促进脑动脉瘤的进展。
Stroke. 2008 Sep;39(9):2603-10. doi: 10.1161/STROKEAHA.107.513648. Epub 2008 Jul 17.
2
Recombinant cathepsin S propeptide attenuates cell invasion by inhibition of cathepsin L-like proteases in tumor microenvironment.重组组织蛋白酶S前肽通过抑制肿瘤微环境中的组织蛋白酶L样蛋白酶来减弱细胞侵袭。
Mol Cancer Ther. 2008 Mar;7(3):538-47. doi: 10.1158/1535-7163.MCT-07-0528.
3
Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease.胞质组织蛋白酶L对发动蛋白的蛋白水解加工是蛋白尿性肾病的一种机制。
J Clin Invest. 2007 Aug;117(8):2095-104. doi: 10.1172/JCI32022.
4
Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice.组织蛋白酶L缺乏可减轻低密度脂蛋白受体基因敲除小鼠的饮食诱导性动脉粥样硬化。
Circulation. 2007 Apr 17;115(15):2065-75. doi: 10.1161/CIRCULATIONAHA.107.688523. Epub 2007 Apr 2.
5
Emerging role of cathepsin S in obesity and its associated diseases.组织蛋白酶S在肥胖及其相关疾病中的新作用。
Clin Chem Lab Med. 2007;45(3):328-32. doi: 10.1515/CCLM.2007.083.
6
Tissue inhibitor of metalloproteinase-2 inhibits T-cell infiltration and preserves pancreatic beta-cell function in an in vitro type 1 diabetes mellitus model.金属蛋白酶组织抑制剂-2在体外1型糖尿病模型中抑制T细胞浸润并维持胰腺β细胞功能。
J Autoimmun. 2006 Aug;27(1):28-37. doi: 10.1016/j.jaut.2006.04.004. Epub 2006 Jun 9.
7
Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25- regulatory T cells.糖皮质激素诱导的肿瘤坏死因子受体家族相关蛋白(高表达)、表达Foxp3的CD25 +和CD25 -调节性T细胞对自身免疫性心肌炎和多器官炎症的控制
J Immunol. 2006 Apr 15;176(8):4748-56. doi: 10.4049/jimmunol.176.8.4748.
8
Where CD4+CD25+ T reg cells impinge on autoimmune diabetes.CD4+CD25+调节性T细胞在自身免疫性糖尿病中发挥作用的环节。
J Exp Med. 2005 Nov 21;202(10):1387-97. doi: 10.1084/jem.20051409.
9
Autoimmune destruction of pancreatic beta cells.胰腺β细胞的自身免疫性破坏。
Am J Ther. 2005 Nov-Dec;12(6):580-91. doi: 10.1097/01.mjt.0000178767.67857.63.
10
Cathepsin B in osteoarthritis: uncontrolled proteolysis in the wrong place.组织蛋白酶B与骨关节炎:在错误部位发生的不受控制的蛋白水解作用
Semin Arthritis Rheum. 2005 Jun;34(6 Suppl 2):24-8. doi: 10.1016/j.semarthrit.2004.03.008.

组织蛋白酶 S、L 和 B 在 NOD 小鼠胰岛炎和糖尿病中的作用。

Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse.

机构信息

Department of Immunology and Howard Hughes Medical Institute, University of Washington, Seattle, WA 98109-8050, USA.

出版信息

J Autoimmun. 2010 Mar;34(2):96-104. doi: 10.1016/j.jaut.2009.07.003. Epub 2009 Aug 6.

DOI:10.1016/j.jaut.2009.07.003
PMID:19664906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2822044/
Abstract

We developed a panel of non-obese diabetic (NOD) mice deficient in major lysosomal cysteine proteases (cathepsins S, L and B) to identify protease enzymes essential for autoimmune diabetes. Null alleles for cathepsins (Cts) S, L or B were introgressed onto the NOD genetic background with 19 Idd markers at homozygosity. Diabetes onset was determined among females aged up to 6 months. We evaluated insulitis and sialadenitis in tissues using histology and computer assisted morphology. NOD mice deficient in Ctss or Ctsb were partially protected from diabetes with incidence at 33% and 28%, respectively, versus wild-type NOD (69%; p < 0.00001). NODs lacking cathepsin L (Ctsl-/-) are completely protected from IDDM, as originally shown by others. Ctsl, Ctss, or Ctsb heterozygous mice were able to develop IDDM, although incidence levels were significantly lower for Ctsb+/- (50%) and Ctsl+/- (55%) as compared to NODs (69%; p < 0.03). Ctsl-/- mice contain functional, diabetogenic T cells and an enriched Foxp3+ regulatory T cell population, and diabetes resistance was due to the presence of an expanded population of regulatory T cells. These data provide additional information about the potency of the diabetogenic T cell population in Ctsl-/- mice which were comparable in potency to wild-type NOD mice. These data illustrate the critical contribution of each of these proteases in determining IDDM in the NOD mouse and provide a useful set of models for further studies.

摘要

我们构建了一组非肥胖型糖尿病(NOD)小鼠,它们缺乏主要的溶酶体半胱氨酸蛋白酶(组织蛋白酶 S、L 和 B),以鉴定对自身免疫性糖尿病至关重要的蛋白酶酶。组织蛋白酶 S、L 或 B 的 null 等位基因被导入 NOD 遗传背景,在纯合状态下带有 19 个 Idd 标记。在年龄不超过 6 个月的雌性中确定糖尿病的发病情况。我们使用组织学和计算机辅助形态学评估组织中的胰岛炎和唾液腺炎。缺乏组织蛋白酶 S(Ctss)或 B(Ctsb)的 NOD 小鼠分别有 33%和 28%的糖尿病发病率,与野生型 NOD(69%)相比得到部分保护(p<0.00001)。正如其他人最初所示,缺乏组织蛋白酶 L(Ctsl-/-)的 NOD 小鼠完全免受 1 型糖尿病的影响。Ctsl、Ctss 或 Ctsb 杂合子小鼠能够发展为 1 型糖尿病,尽管 Ctsb+/-(50%)和 Ctsl+/-(55%)的发病率水平明显低于 NOD(69%)(p<0.03)。Ctsl-/-小鼠含有功能正常的致糖尿病 T 细胞和丰富的 Foxp3+调节性 T 细胞群,糖尿病抵抗是由于存在扩展的调节性 T 细胞群。这些数据提供了有关 Ctsl-/-小鼠中致糖尿病 T 细胞群体效力的更多信息,其效力与野生型 NOD 小鼠相当。这些数据说明了这些蛋白酶中的每一种在确定 NOD 小鼠中的 1 型糖尿病中的关键作用,并为进一步研究提供了一组有用的模型。